Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 216-372-4 | CAS number: 1569-01-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Developmental toxicity / teratogenicity
Administrative data
- Endpoint:
- developmental toxicity
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- August 1988 - August 1992
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP-study equivalent to OECD guideline 414.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 992
- Report date:
- 1992
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 414 (Prenatal Developmental Toxicity Study)
- GLP compliance:
- yes (incl. QA statement)
- Limit test:
- no
Test material
- Reference substance name:
- 1-propoxypropan-2-ol
- EC Number:
- 216-372-4
- EC Name:
- 1-propoxypropan-2-ol
- Cas Number:
- 1569-01-3
- Molecular formula:
- C6H14O2
- IUPAC Name:
- 1-propoxypropan-2-ol
- Details on test material:
- - Name of test material (as cited in study report): PROPASOL Solvent P
- Analytical purity: > 99%
- Purity test date: before and after exposure period
- Lot/batch No.: S077744
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Breeding Laboratories Inc.
- Age at study initiation: 11 weeks (males) & 10 weeks (females)
- Weight at study initiation:
- Fasting period before study: n.a.
- Housing: individually in stainless steel wire-mesh cages
- Diet (e.g. ad libitum): ad libitum (during non-exposure periods)
- Water (e.g. ad libitum): ad libitum (during non-exposure periods)
- Acclimation period: 2 weeks
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 18.3-21.1°C
- Humidity (%): 40-70 % (except for a single 3.5 h interval of 70-74% and a spike (less than 30 min) of 70-84%)
- Air changes (per hr): no data
- Photoperiod (hrs dark / hrs light): 12-hour
Administration / exposure
- Route of administration:
- inhalation: vapour
- Type of inhalation exposure (if applicable):
- whole body
- Vehicle:
- unchanged (no vehicle)
- Details on exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: rectangular shaped chambers made of glass and stainless steel (volume 4320 l); an orifice plate was positioned in the exhaust duct of the chamber and was conntected to a Dwyer Magnehelic Pressure Gauge; chambers were iluminated with artificial room light
- Method of conditioning air: Liquid PROPASOL Solvent P was metered from a piston pump into a heated glass evaporator. The temperature in the evaporator was maintained at the lowest level sufficient to vaporize the liquid. The resultant vapor was carried into the chamber by passage of conditioned air through the evaporators. Chamber atmospheres containing PROPASOL Solvent P were filtered before leaving an exhaust stack.
- Temperature, humidity, pressure in air chamber: chamber temperature and relative humidity were recorded approximately every 30 minutes during each 6-hour exposure
- Air flow rate: 1000 - 1300 l/min
- Air change rate: 14 changes per hour
TEST ATMOSPHERE
Each chamber was monitored for concentration approximately once every 30 minutes during each 6-hour exposure. Daily nominal concentrations (an estimated concentration calculated from the amount of test material delivered and the chamber airflow during the exposure period) were calculated for each chamber. Chamber distribution of PROPASOL Solvent P was evaluated at five different locations within each of the exposure chambers. - Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- A Perkin-Elmer Model 3920B gas chromatograph equipped with a flame ionization detector was used to monitor the concentrations of the n-propoxypropanol vapor concentrations in the exposure chambers. The GC column was an SP2100 6 ft x 1/8 in stainless steel column. The gases for the chromatograph were obtained from Linde Corporation. The nitrogen and hydrogen were Ultra High Purity grade and the air was breathing quality. A Spectra-Physics SP 4270 Computer Integrator was used to determine peak areas and to calculate concentrations.
Calibration of the gas chromatograph was done with dynamically generated gas standards of PROPASOL Solvent P prepared by syringe injection of test material into Tedler gas bag. The series of standards encompassed the entire range of vapor concentrations generated in the exposure chambers.A linear calibration curve was obtained when areas (integration counts) were plotted versus the gas standard concentration of each component of the mixture. The calibration factors (RF) were calculated as: RF=area/concentration. The mean RF for all valid injections of standard was used in subsequent microprocessor calculations. This calibration factor was checked at least once a week during the exposure period. - Details on mating procedure:
- Rats were bred 1:1 (one male at least 300 g; one female at least 200g) in mating cages, and the females were examined twice daily for vaginal copulation plugs. Each male was used once in this study. The date a copulation plug was found was designated gesteational day (gd) 0. Plug-positive stufdy females (25) were housed individually after mating for the duration of the study.
- Duration of treatment / exposure:
- gd 6 through 15
- Frequency of treatment:
- 6 hours/day
- Duration of test:
- gd 0 - gd 21
Doses / concentrationsopen allclose all
- Remarks:
- Doses / Concentrations:
100 ppm
Basis:
nominal conc.
- Remarks:
- Doses / Concentrations:
750 ppm
Basis:
nominal conc.
- Remarks:
- Doses / Concentrations:
1500 ppm
Basis:
nominal conc.
- No. of animals per sex per dose:
- 25
- Control animals:
- yes, concurrent no treatment
- Details on study design:
- - Dose selection rationale: target concentrations of 0, 100, 750 and 1500 ppm were determined based on an exposure range-finding study also performed on pregnant CD (Sprague-Dawley) rats.
Examinations
- Maternal examinations:
- DETAILED CLINICAL OBSERVATIONS: Yes
- Time schedule: daily
BODY WEIGHT: Yes
- Time schedule for examinations: gd 0, 6, 9, 12, 15, 18 and 21.
FOOD AND WATER CONSUMPTION : Yes
- Time schedule for examinations: measured at 3 to 4 day intervals throughout the study (gd 0 through 21) and averages for the preexposure, exposure and postexposure periods were calculated.
POST-MORTEM EXAMINATIONS: Yes
- Sacrifice on gestation day 21
- Organs examined:
Gravid uterus, ovaries (including corpora lutea), cervix, vagina, and abdominal and thoracic cavities were examined grossly. Ovarian corpora lutea of pregnancy were counted. The maternal liver was weighed. Both eyes from all study females were removed and preserved in 10% neutral bufferen formalin. One eye, selected by the study director based on the ophthalmic examination, was embedded in plastic and evaluated by periodic acid-Schiff stain. Each uterus was externally examined for signs of hemorrhage, removed from the peritoneal cavity, weighed and dissected longitudinally to expose the contents. All live and dead fetuses and resorption sites (early and late) were noted and recorded. Uteri from females that appeared nongravid were placed in a 10% ammonium sulfide solution for detection of early resorptions.
OTHER:
Prior to initiation of exposures and following exposure on the last day of rat exposures, detailed ophthalmic examinations were performed on each study animal. - Ovaries and uterine content:
- The ovaries and uterine content was examined after termination: Yes
Examinations included:
- Gravid uterus weight: Yes
- Number of corpora lutea: Yes
- Number of implantations: Yes
- Number of early resorptions: Yes
- Number of late resorptions: Yes - Fetal examinations:
- - External examinations: Yes: [all per litter]
- Soft tissue examinations: Yes: [half per litter ]
- Skeletal examinations: Yes: [half per litter]
- Head examinations: Yes: [half per litter]
All live fetuses were weighed, sexed and were examined for external malformations including cleft palate, and variations. Approximately 50% of the live fetuses in each litter (even-numbered fetuses from litters with an even number of live fetuses) were examined for thoracic and abdominal visceral abnormalities. The fetuses which received visceral examinations were decapitated and their heads were fixed in Bouin's solution for examination of craniofacial structures. All live fetuses (50% intact, 50% decapitated) in each litter were eviscerated and then processed for skeletal staining with alizarin red S. Intact fetuses (not decapitated) were examined for skeletal malformations and variations. All fetal skeletal preparations were retained. - Statistics:
- The unit of comparison was the pregnant dam or the litter. Results of the quantitative continuous variables (e.g., maternal body weights, liver weights, etc.) were intercompared for the three exposure groups and control group by use of Levene's test for equal variances, analysis of variance (ANOVA), and t-tests with Bonferroni probabilities. The t-tests were used when the F value from the ANOVA was significant. When Levene's test indicated homogeneous variances, and the ANOCVA was significant, the pooled t-test was used for pairwise comparisons. When Levene's test indicated heterogeneous variances, all groups were compared by an ANOVA for unequal variances followed, when necessary, by the seperate variance t-test for pairwise comparisons.
Nonparametric data obtained following laparohysterectomy were statistically treated using the Kruskal-Wallis test followed by the Mann-Whitney U test when appropriate. Incidence data were compared using Fisher's Exact Test. For all statistical tests, the probability value of 0.05 (two-tailed) was used as the criterion for significance. - Indices:
- not applicable
Results and discussion
Results: maternal animals
Maternal developmental toxicity
- Details on maternal toxic effects:
- Maternal toxic effects:yes
Details on maternal toxic effects:
Maternal effects observed at 1500 ppm were eye irritation, significant reductions in body weight gain early in the exposure period (days 6-9), and reduced food consumption during the exposure period. In a single dam at 1500 ppm, corneal opacity was grossly observed. Subsequent histological evaluation confirmed the presence of corneal ulceration and associated keratitis as well as corneal and scleral mineralization and scleral granulomas.
Effect levels (maternal animals)
open allclose all
- Dose descriptor:
- NOEL
- Effect level:
- 750 ppm
- Basis for effect level:
- other: maternal toxicity
- Dose descriptor:
- NOEL
- Effect level:
- 750 ppm
- Basis for effect level:
- other: developmental toxicity
Results (fetuses)
- Details on embryotoxic / teratogenic effects:
- Embryotoxic / teratogenic effects:yes
Details on embryotoxic / teratogenic effects:
Poorly ossified hindlimb phalanges were observed in litters of the 1500 ppm group.
Fetal abnormalities
- Abnormalities:
- not specified
Overall developmental toxicity
- Developmental effects observed:
- not specified
Applicant's summary and conclusion
- Conclusions:
- Exposure to PROPASOL Solvent P vapor by inhalation during organogenesis in CD (Sprague-Dawley) rats resulted in slight maternal and developmental toxicity at 1500 ppm. The "no observable effect level" (NOEL) for both maternal and developmental toxicity was 750 ppm.
- Executive summary:
Timed-pregnant CD (Sprague-Dawley) rats were exposed to PROPASOL Solvent P vapor for six hours/day on gestational days (GD) 6 through 15. Twenty-five rats per group were exposed to PROPASOL Solvent P at target concentrations of 0, 100, 750, or 1500 ppm. The corresponding mean analytical concentrations were 0, 98.4, 755, and 1524 ppm. Maternal clinical signs were taken daily, and body weights were measured on gd 0, 6, 9, 12, 15, 18 and 21. Maternal food and water consumption were measured throughout gestation, gd 0 -21. In addition, prior to expsoure and immediately following the last exposure day, the eyes of dams were examined by a veterinary ophthalmologist. At scheduled sacrifice on gd 21, maternal body weight, gravid uterine weight and liver weight were measured. Maternal eyes were fixed in neutral buffered formalin for subsequent histological examination.Ovarian corpora lutea of pregnancy were counted and all uterine implantation sites were identified and recorded: resorptions (early or late), dead fetuses and live fetuses. All live fetuses were examined for external malformations (including cleft palate) and variations. Approximately 50% per litter were examined for visceral malformations and variations (including craniofacial alterations) and approximately 50% per litter (intact fetuses) were examined for skeletal malformations and variations.
Maternal effects observed at 1500 ppm were eye irritation, significant reductions in body weight gain early in the exposure period (days 6 -9), and reduced food consumption during the exposure period. In a single dam at 1500 ppm, corneal opacity was grossly observed. Subsequent histological evaluation confirmed the presence of corneal ulceration and associated keratitis as well as corneal and slecral mineralization and scleral granulomas. Gestational parameters, including number of viable implantations per litter, number of nonviable implantations per litter and sex ratio, were unaffected by test chemical exposure. Fetal body weights (total, males or females) per litter were equivalent across exposure groups. There were no treatment-related changes in the incidence of individual or pooled external, visceral or skeletal malformations or of total malformations. There were no treatment-related increases in the incidence of individual external or visceral variations at any exposure level. Poorly ossified hindlimb phalanges were observed in litters of the 1500 ppm group. The incidences of variations by category, or of total variations were equivalent across groups.
In conclusion, expsoure to PROPASOL Solvent P vapor by inhalation during organogenesis in CD (Sprague-Dawley) rats resulted in slight maternal and developmental toxicity at 1500 ppm. The "no observable effect level" (NOEL) for both maternal and developmental toxicity was 750 ppm.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.